Who invested in RQ Bio?
RQ Bio's investors include Frazier Life Sciences, Wellington Management, Forbion Capital Partners, Oxford Science Enterprises and EQT Life Sciences, and 3 more on record. Frazier Life Sciences led its latest round.
United Kingdom · Series A startup
One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 4 months ago
Funding summaryUpdated 26 Oct 2026
$115Mraised across 1 round since 2026, from 2 sources
RQ Bio's investors include Frazier Life Sciences, Wellington Management, Forbion Capital Partners, Oxford Science Enterprises and EQT Life Sciences, and 3 more on record. Frazier Life Sciences led its latest round.
RQ Bio has raised $115M across 1 round since 2026.
RQ Bio's most recent round was a Series A of $115M in Jun 2026, led by Frazier Life Sciences.
Its most recent round, $115M in Jun 2026, is also its largest on record.
RQ Bio's first round on record, in Jun 2026, was backed by Frazier Life Sciences, Wellington Management and Forbion Capital Partners and 5 others.
RQ Bio's latest named round is a Series A, in Jun 2026.
RQ Bio is based in the United Kingdom.
Frazier Life Sciences led the Series A in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.